Some researchers find that thigh injections produce fewer injection site reactions, while others prefer the abdomen for its reliability
Key signs include: Peripheral neuropathy: tingling or numbness in the hands and feet Mood changes: irritability, anxiety, depressive symptoms Fatigue and weakness: beyond what caloric restriction alone explains Skin rashes: seborrheic dermatitis, particularly on the face and scalp Cracked lips and mouth corners: a condition called cheilosis Impaired immune function: more frequent infections than usual Confusion or difficulty concentrating: related to impaired neurotransmitter synthesis If you are on tirzepatide and experiencing persistent tiredness , anxiety , or body aches that do not resolve with standard management strategies, it may be worth having your B6 levels tested
Anyone receiving retatrutide within a clinical trial should seek prompt medical advice from their trial team if they experience any of the following: Persistent or severe vomiting that prevents adequate fluid or food intake Signs of dehydration , including dizziness, reduced urination, or extreme thirst Severe or persistent abdominal pain , which may rarely indicate pancreatitis or a gallbladder problem Right upper quadrant pain, fever, or jaundice , which may suggest acute gallbladder disease (cholelithiasis or cholecystitis) a recognised risk with GLP-1-based therapies and with rapid weight loss [11] [12] Symptoms of hypoglycaemia (particularly if taking concomitant insulin or sulphonylureas), such as shakiness, sweating, or confusion Injection site reactions that are worsening, infected, or not resolving Retatrutide has not been studied in pregnancy or breastfeeding, and use during pregnancy or whilst breastfeeding is not recommended until safety data are available
There are other effects well get into, but at a high level: GLP-1 = less hunger
